Evaluation of the First Cytostatically Active 1-Aza-9-oxafluorenes as Novel Selective CDK1 Inhibitors with P-Glycoprotein Modulating Properties

Evaluation of the First Cytostatically Active 1-Aza-9-oxafluorenes as Novel Selective CDK1 Inhibitors with P-Glycoprotein Modulating Properties Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors:  Synthesis and Biological Effects Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells Pyrazolo[3,4-c]pyridazines as Novel and Selective Inhibitors of Cyclin-Dependent Kinases Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators Synthesis and primary evaluation of quinoxalinone derivatives as potent modulators of multidrug resistance Structure–activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK) Inhibitors Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure–activity relationships and bioanalytical studies